A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2006
11/07/2006	CA2248032C Serum cholesterol lowering agent
11/07/2006	CA2244777C 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
11/07/2006	CA2158268C N-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
11/07/2006	CA2130703C Diacyl-substituted guanidines, a process for their preparation, their use as medicine or diagnostic aid, and medicine containing them
11/02/2006	WO2006116435A2 Methods of treating atherosclerosis
11/02/2006	WO2006116401A1 C-5 substituted quinazolinone derivatives as selective estrogen receptor beta modulators
11/02/2006	WO2006116349A2 Sustained release formulation and dosing schedules of leukotriene synthesis inhibitor for human therapy
11/02/2006	WO2006115436A1 Medicinal agent for preventing progression of apoptotic and jugulating necrotic changes in the organism tissues
11/02/2006	WO2006115321A1 Composition comprising the extract of salvia miltiorrhiza bge showing enhancing activity for the prevention or treatment of blood circulatory disease.
11/02/2006	WO2006115295A1 Compositions and methods for treating hemostasis disorders associated with clec-2 signal transduction
11/02/2006	WO2006115279A1 Composition for preservation of vascular endothelium
11/02/2006	WO2006115247A1 HIGHLY SELECTIVE Rho-KINASE INHIBITOR
11/02/2006	WO2006115245A1 4-ethynylisoquinoline derivative and pharmaceutical preparation comprising the same
11/02/2006	WO2006115244A1 4-bromoisoquinoline derivative and pharmaceutical preparation comprising the same
11/02/2006	WO2006115188A1 Heterocyclic compound
11/02/2006	WO2006115134A1 Novel benzofuran derivative, pharmaceutical composition comprising the same, and use of the derivative or composition
11/02/2006	WO2006114441A1 Blood pressure lowering protein hydrolysates
11/02/2006	WO2006114439A2 Novel nutraceutical compositions
11/02/2006	WO2006114195A1 Compositions comprising tripeptides inhibiting ace
11/02/2006	WO2006114194A1 Peptides having a health benefit and compositions comprising them
11/02/2006	WO2006093823A9 2- [ isoquinolin-s - carbonyl ) amino] -propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis
11/02/2006	WO2006086500A3 Compositions and methods for treating vascular, autoimmune and inflammatory diseases
11/02/2006	WO2006086498A3 Treatment of vascular, autoimmune and inflammatory diseases using low dosages of impdh inhibitors
11/02/2006	WO2006072809A3 Formulations that optimize intracellular concentration of nicotinamide adenine (nad+) and methods of use to protect cells and treat diseases and conditions
11/02/2006	WO2006067224A3 Spiro-benzodioxole and spiro-benzodioxane compounds as orexin receptor antagonists
11/02/2006	WO2006063408A8 Compositions and methods for treating cardiovascular disorders
11/02/2006	WO2006031467A3 Isolated lineage negative hematopoietic stem cells and methods of treatment therewith
11/02/2006	US20060248601 Modification of organelle metabolism by unc-51-like kinases roma1 or 2tm proteins
11/02/2006	US20060247448 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
11/02/2006	US20060247310 Body temperature elevating agents
11/02/2006	US20060247307 imino compound as antiinflammatory agent, anticarcinogenic agent for treating chronic inflammation and cancers; activating peroxisome proliferator-activated receptor
11/02/2006	US20060247303 7H-dibenzo[b,g][1,5]dioxocin-5-one derivatives and use thereof
11/02/2006	US20060247290 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
11/02/2006	US20060247280 Non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis; 3-Benzyl-5-(benzylthio)-1,2,4-triazole
11/02/2006	US20060247261 Pyrimidine compounds
11/02/2006	US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
11/02/2006	US20060247228 Phenylazole compounds production process and antioxidants
11/02/2006	US20060247179 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
11/02/2006	US20060247160 Administering a polypeptide or biologically active fragment; reducing body mass; metabolic-related diseases, hyperlipidemias, atherosclerosis, diabetes, and hypertension
11/02/2006	US20060246525 Method of screening remedy for heart disease and medicinal composition for treating heart disease
11/02/2006	US20060246110 Sustained release pharmaceutical composition
11/02/2006	US20060246069 Inflammation and immunopathy caused by human anti-human Monocyte chemoattractant protein-1
11/02/2006	US20060246066 Cleavable reagents for specific delivery to disease sites
11/02/2006	US20060246047 Peptide wirh apoptosis-inhibiting activity
11/02/2006	US20060243276 Methods for treating rhinitis and conjunctivitis
11/02/2006	EP1717230A1 Fused-ring 4-oxopyrimidine derivative
11/02/2006	EP1717229A1 Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein
11/02/2006	EP1717226A1 2,7-substituted 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octan amide derivatives as renin inhibitors for the treatment of hypertension
11/02/2006	EP1717225A1 Bicyclic amide derivatives
11/02/2006	EP1716869A1 Drug for preventing or treating heart diseases comprising cd9 gene
11/02/2006	EP1716865A1 Paraoxonase-containing pharmaceutical preparation
11/02/2006	EP1716148A2 Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof
11/02/2006	EP1716137A1 Substituted quinoline compounds
11/02/2006	EP1716118A1 Tetrahydrobenzo[d]azepin-2- one derivatives and the use thereof for treating cardiovascular diseases
11/02/2006	EP1715881A1 Cysteine rich peptides for improving thiol homeostasis
11/02/2006	EP1715870A1 Inhibition of protein kinase c-related kinase (prk) as a treatment for cardiac hypertrophy and heart failure
11/02/2006	EP1517682B1 Pharmaceutical formulation comprising non-peptide renin inhibitor and surfactant
11/02/2006	EP1448195B1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
11/02/2006	EP1434624B1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
11/02/2006	EP1395568B1 4-aminopyrimidine derivatives
11/02/2006	EP1343773B1 Thiazole derivatives for traeing ppar related disorders
11/02/2006	EP1337243B1 Delayed-release pharmaceutical formulations containing proinsulin c-peptide
11/02/2006	EP1315700B1 Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine
11/02/2006	EP1296923B1 Aspirin-triggered lipid mediators
11/02/2006	EP1223925B1 Fatty acid derivative for the treatment of external secretion disorders
11/02/2006	EP1214295B1 Hydroxyacetamidobenzenesulphonamide derivatives
11/02/2006	EP1192133B1 N-cyclopentyl modulators of chemokine receptor activity
11/02/2006	EP1107768B1 STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE
11/02/2006	EP1036063B1 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
11/02/2006	EP1009417B1 Dietary supplements containing natural ingredients
11/02/2006	EP1003721B1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
11/02/2006	EP0823908B1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
11/02/2006	EP0769961B1 Use of bacterial enzymes e.g. heparinases, chondroitinases for modulating wound healing processes
11/02/2006	CA2605771A1 Methods of treating atherosclerosis
11/02/2006	CA2605674A1 Sustained release formulation and dosing schedules of leukotriene synthesis inhibitor for human therapy
11/02/2006	CA2605594A1 Heterocyclic compound
11/02/2006	CA2604967A1 Pyrimidine derivatives and their use as p2y12 receptor antagonists
11/02/2006	CA2603237A1 Novel nutraceutical compositions
11/02/2006	CA2600506A1 Blood pressure lowering protein hydrolysates
11/01/2006	CN1856504A Anti-infarction molecules
11/01/2006	CN1856501A Amidomethyl substituted 1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid derivatives, process and intermediate products for their preparation and medicaments containing these compou
11/01/2006	CN1856499A New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1
11/01/2006	CN1856339A Iloprost in combination therapies for the treatment of pulmonary arterial hypertension
11/01/2006	CN1856326A Combinations of a VEGF receptor inhibitor with other therapeutic agents
11/01/2006	CN1856305A Pyridine derivatives and use thereof as urotensin II antagonists
11/01/2006	CN1854300A Recombinant plasmid containing PON gene and its use
11/01/2006	CN1854148A Astragalus total heteroside extract and its production
11/01/2006	CN1854138A 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias
11/01/2006	CN1854135A Heteronuclear compound with dicyandiamide connection and its medicinal use
11/01/2006	CN1853728A Method prescription and use for improving medicine or nutrient oral absorption
11/01/2006	CN1853711A Xinmaikangzhong Chinese medicinal composition and preparation thereof
11/01/2006	CN1853706A Apoplectic Naoluofang
11/01/2006	CN1853705A Medicine for treating cardiovascular disease
11/01/2006	CN1853702A Chinese medicinal preparation for lowering blood sugar, blood fat and blood pressure, improving blood flow and immune and its making method
11/01/2006	CN1853701A Effective part of Sang Medicine and preparation thereof
11/01/2006	CN1853696A Medicine for treating coronary heart disease and preparation thereof
11/01/2006	CN1853689A Chinese medicinal preparation for treating heart cerebrovascular disease and making method thereof
11/01/2006	CN1853688A Chinese medicinal preparation for treating heart cerebrovascular disease and ischemic apoplexia and making method thereof
11/01/2006	CN1853679A Medicinal composition for treating cervical spondylosis and preparation thereof
11/01/2006	CN1853678A Chinese medicinal preparation for treating heart cerebrovascular disease and making method thereof

1 ... 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 ... 1595